Please try another search
| YTD | 3M | 1Y | 3Y | 5Y | 10Y | |
|---|---|---|---|---|---|---|
| Growth of 1000 | 1092 | 984 | 1155 | 1503 | 1574 | - |
| Fund Return | 9.19% | -1.6% | 15.48% | 14.56% | 9.49% | - |
| Place in category | 1022 | 1524 | 933 | 540 | 424 | - |
| % in Category | 44 | 64 | 43 | 27 | 26 | - |
| Name | Rating | Total Assets | YTD% | 3Y% | 10Y% | |
|---|---|---|---|---|---|---|
| LU1698129266 | 9.51B | 13.95 | 19.17 | - | ||
| LU1599216113 | 3.65B | 17.05 | 17.47 | - | ||
| LU2767497063 | 3.65B | -6.59 | - | - | ||
| LU2229033274 | 982.35M | 29.21 | 27.20 | - | ||
| LU0996561741 | 155.31M | 16.92 | 1.39 | 3.60 |
| Name | Rating | Total Assets | YTD% | 3Y% | 10Y% | |
|---|---|---|---|---|---|---|
| Eleva Euro Slct Class A2 EUR Acc | 9.33B | 7.82 | 15.25 | 9.83 | ||
| Eleva Euro Slct Class I EUR Acc | 9.33B | 8.74 | 16.38 | 11.00 | ||
| Eleva Euro Slct Class R EUR Acc | 9.33B | 8.70 | 16.35 | 10.93 | ||
| Eleva Euro Slct Class A1 EUR Acc | 9.33B | 8.23 | 15.75 | 10.36 | ||
| LU3022520095 | 8.32B | 9.88 | - | - |
| Name | ISIN | Weight % | Last | Change % | |
|---|---|---|---|---|---|
| ASML Holding | NL0010273215 | 4.33 | 1,496.00 | +1.27% | |
| HSBC | GB0005405286 | 2.92 | 1,397.20 | -2.16% | |
| Novartis | CH0012005267 | 2.54 | 124.20 | -0.40% | |
| Siemens AG | DE0007236101 | 2.38 | 266.20 | -1.64% | |
| Roche Holding Participation | CH1499059983 | 2.34 | 380.10 | +0.24% |
| Type | 5 Min | 15 Min | Hourly | Daily | Monthly |
|---|---|---|---|---|---|
| Moving Averages | - | - | - | Buy | Strong Buy |
| Technical Indicators | - | - | - | Strong Buy | BUY |
| Summary | Neutral | Neutral | Neutral | Strong Buy | Strong Buy |
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review